Continuous advances in critical patient care have enabled to develop efficient hemodynamic monitoring systems featuring non-invasive technology and expanded parameters such as continuous BP measurements, measurement of cardiac output by pulse contour method, among others.




August 19, 2022 —  Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist.

August 19, 2022 —  Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. became the second in the world to successfully implant the Impella Bridge-to-Recovery (BTR) heart pump for the technology’s U.S. Food and Drug Administration (FDA) early feasibility study (EFS) investigational device exemption (IDE).

August 19, 2022 —  Nicholas Lam was building a set in his performing arts high school’s scene shop when he began feeling a tingling, numbing sensation in his left arm. 

Lam thought it felt similar to when his foot would “fall asleep” – except he wasn’t lying on his arm. He wondered if he pinched a nerve. Within the next 45 minutes, the muscle weakness began spreading to the entire left side of Lam’s body. 


As the cardiology community commemorates the importance of heart health on World Heart Day, Sept. 29, here’s a quick look back in heart history at four individuals who earned their place in the National Inventors Hall of Fame.


August 18, 2022 — Six digital healthcare start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program orchestrated by GE Healthcare

August 18, 2022 — A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth lower in carriers of the variant compared to the population on average. 

The protective effect of the newly discovered variant against coronary heart disease is likely to be caused by the below-average arterial stiffness of variant carriers. 

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm that is a leading cause of 

Subscribe Now